BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 16861658)

  • 1. Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients.
    Aichele D; Schnare M; Saake M; Röllinghoff M; Gessner A
    Infect Immun; 2006 Aug; 74(8):4708-14. PubMed ID: 16861658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa in cystic fibrosis: pyocyanin negative strains are associated with BPI-ANCA and progressive lung disease.
    Carlsson M; Shukla S; Petersson AC; Segelmark M; Hellmark T
    J Cyst Fibros; 2011 Jul; 10(4):265-71. PubMed ID: 21463973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BPI-ANCA of pediatric cystic fibrosis patients can impair BPI-mediated killing of E. coli DH5alpha in vitro.
    Schultz H; Schinke S; Mosler K; Herlyn K; Schuster A; Gross WL
    Pediatr Pulmonol; 2004 Feb; 37(2):158-64. PubMed ID: 14730661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies against bactericidal/permeability-increasing protein (BPI-ANCA) in cystic fibrosis patients treated with azithromycin.
    Rotschild M; Elias N; Berkowitz D; Pollak S; Shinawi M; Beck R; Bentur L
    Clin Exp Med; 2005 Jul; 5(2):80-5. PubMed ID: 16096858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-neutrophil cytoplasmatic antibodies and lung disease in cystic fibrosis.
    Dorlöchter L; Carlsson M; Olafsdottir EJ; Røksund OD; Rosendahl K; Fluge G
    J Cyst Fibros; 2004 Aug; 3(3):179-83. PubMed ID: 15463905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis.
    Carlsson M; Eriksson L; Pressler T; Kornfält R; Mared L; Meyer P; Wiik A; Wieslander J; Segelmark M
    J Cyst Fibros; 2007 May; 6(3):228-33. PubMed ID: 17166780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scorpionfish BPI is highly active against multiple drug-resistant
    Holzinger JM; Toelge M; Werner M; Ederer KU; Siegmund HI; Peterhoff D; Blaas SH; Gisch N; Brochhausen C; Gessner A; Bülow S
    Elife; 2023 Jul; 12():. PubMed ID: 37461324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BPI-ANCA is expressed in the airways of cystic fibrosis patients and correlates to platelet numbers and Pseudomonas aeruginosa colonization.
    Hovold G; Lindberg U; Ljungberg JK; Shannon O; Påhlman LI
    Respir Med; 2020; 170():105994. PubMed ID: 32843162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
    Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-neutrophil cytoplasmic antibodies directed against the bactericidal/permeability-increasing protein (BPI) in pediatric cystic fibrosis patients do not recognize N-terminal regions important for the anti-microbial and lipopolysaccharide-binding activity of BPI.
    Schultz H; Csernok E; Schuster A; Schmitz TS; Ernst M; Gross WL
    Pediatr Allergy Immunol; 2000 May; 11(2):64-70. PubMed ID: 10893006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensive endoscopic image-guided sinus surgery decreases BPI-ANCA in patients with cystic fibrosis.
    Aanaes K; Rasmussen N; Pressler T; Segelmark M; Johansen HK; Lindberg U; Høiby N; Carlsson M; Wieslander J; Buchwald C
    Scand J Immunol; 2012 Dec; 76(6):573-9. PubMed ID: 22946777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G
    APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-neutrophil cytoplasmic antibodies (ANCA) in serum and bronchoalveolar lavage fluids of cystic fibrosis patients and patients with idiopathic bronchiectasis.
    Cobanoğlu N; Ozcelik U; Cetin I; Yalçin E; Doğru D; Kiper N; Bakkaloğlu A
    Turk J Pediatr; 2010; 52(4):343-7. PubMed ID: 21043377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intratracheal administration of novispirin G10 on a rat model of mucoid Pseudomonas aeruginosa lung infection.
    Song Z; Wu H; Mygind P; Raventos D; Sonksen C; Kristensen HH; Høiby N
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3868-74. PubMed ID: 16127064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas-induced lung damage in cystic fibrosis correlates to bactericidal-permeability increasing protein (BPI)-autoantibodies.
    Carlsson M; Eriksson L; Erwander I; Wieslander J; Segelmark M
    Clin Exp Rheumatol; 2003; 21(6 Suppl 32):S95-100. PubMed ID: 14740434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies.
    Schultz H; Weiss J; Carroll SF; Gross WL
    J Leukoc Biol; 2001 Apr; 69(4):505-12. PubMed ID: 11310835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bovine salivary proteins BSP30a and BSP30b are independently expressed BPI-like proteins with anti-Pseudomonas activity.
    Haigh B; Hood K; Broadhurst M; Medele S; Callaghan M; Smolenski G; Dines M; Wheeler T
    Mol Immunol; 2008 Apr; 45(7):1944-51. PubMed ID: 18055015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BPI-ANCA Provides Additional Clinical Information to Anti-Pseudomonas Serology: Results from a Cohort of 117 Swedish Cystic Fibrosis Patients.
    Lindberg U; Carlsson M; Hellmark T; Segelmark M
    J Immunol Res; 2015; 2015():947934. PubMed ID: 26273683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A murine antibacterial ortholog to human bactericidal/permeability-increasing protein (BPI) is expressed in testis, epididymis, and bone marrow.
    Lennartsson A; Pieters K; Vidovic K; Gullberg U
    J Leukoc Biol; 2005 Mar; 77(3):369-77. PubMed ID: 15590754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.